Active Litigation
Olympus Scope Lawsuit Facts
TorHoerman Law is investigating claims for the Olympus Scope Lawsuit.
Active Litigation
TorHoerman Law is investigating claims for the Olympus Scope Lawsuit.
There is currently no established average settlement amount for an Olympus scope lawsuit because prior resolutions have largely been confidential and the current litigation has not produced a global settlement or compensation matrix.
Settlement value may depend on the severity of the illness, the length of hospitalization, permanent complications, lost income, and the strength of evidence connecting a scope-related infection to the device.
Injured patients who developed a serious infection after an Olympus scope procedure may be able to pursue compensation if the evidence supports allegations involving defective or contaminated medical devices.
This page explains what is currently known about prior Olympus settlements, how attorneys may evaluate potential case value, and which injuries and damages could affect compensation.
TorHoerman Law is investigating Olympus scope infection claims and can review the medical and device evidence involved in an individual case.

An Olympus scope lawsuit may seek compensation when a patient develops a serious infection after a procedure involving an allegedly contaminated or defective Olympus scope.
Olympus manufactures reusable medical scopes used to examine areas such as the digestive tract, and these devices must be thoroughly cleaned, disinfected, dried, and stored before they are used on another patient.
Research involving gastrointestinal endoscopes has documented biological residue and viable microorganisms on some devices after reprocessing, raising concerns about potential infection risks when cleaning or reprocessing is ineffective.
Lawsuits involving Olympus devices allege that contaminated scopes exposed patients to dangerous bacteria that caused severe infections requiring hospitalization and additional medical treatment.
Infections linked to contaminated medical equipment can lead to sepsis, organ failure, bloodstream infections, prolonged antibiotic treatment, and other serious complications.
Although prior Olympus scope infection cases have reached settlements, many reported resolutions were confidential, and there is currently no established average settlement amount or standard payout for these claims.
The potential value of an individual case depends on factors such as the severity of the infection, length of hospitalization, permanent injuries, economic losses, and the strength of the evidence connecting the infection to the scope.
Medical device manufacturers may face product liability claims when plaintiffs allege that a defect, inadequate warning, repair problem, or other issue contributed to patient injuries.
If you or a loved one developed a serious infection after an Olympus scope procedure, contact TorHoerman Law for a free consultation to learn whether you may qualify to pursue compensation.
You can also use the chat feature on this page for a free case evaluation.
There is currently no reliable average settlement amount for an Olympus lawsuit involving contaminated scopes or post-procedure infections.
Several earlier Olympus scope cases reached settlements, but the financial terms were generally confidential, leaving too little public data to calculate a meaningful average.
The current wave of cases has also not produced a global settlement, compensation matrix, or sufficient number of public resolutions to establish standard payout figures.
Settlement value is expected to depend heavily on the severity of the bacterial infection, the length of hospitalization, the treatment required, and whether the patient suffered permanent complications.
A claim involving a life-threatening infection, septic shock, organ failure, multiple surgeries, or wrongful death may involve substantially greater damages than a case in which the patient eventually made a full recovery.
Attorneys also consider lost income, future medical costs, pain and suffering, and the strength of the evidence connecting the Olympus scope to the infection.
Because these factors vary significantly from one patient to another, historical verdicts and confidential settlements should not be treated as predictors of what a current claim may be worth.
TorHoerman Law evaluates each Olympus scope claim individually based on the medical evidence, device history, damages, and circumstances surrounding the infection.
Tier 1 Olympus scope claims involve the most severe outcomes, including septic shock, multiple-organ failure, permanent disability, extensive surgery, prolonged intensive care, or death.
Endoscopes are used in hundreds of thousands of endoscopic procedures each year, and reusable devices must be properly cleaned, disinfected, dried, and stored between patients.
When a reusable Olympus scope is alleged to have transmitted a serious bacterial infection, the resulting illness can require aggressive treatment and lead to lasting medical consequences.
Claims involving permanent organ damage, loss of function, or extensive future medical needs may include substantial economic damages in addition to pain and suffering and other non-economic losses.
Wrongful death cases may also seek compensation for losses available to surviving family members or the estate under applicable state law.
The value of a catastrophic injury claim can depend on the length of hospitalization, ICU treatment, surgeries, permanent impairment, lost earning capacity, future care needs, and the strength of the evidence connecting the infection to the Olympus device.
These cases may carry the greatest potential settlement value, but no outcome or compensation amount can be guaranteed.
Tier 2 Olympus scope claims generally involve patients who developed a severe infection requiring substantial medical treatment but did not suffer the permanent catastrophic injuries or death associated with Tier 1 cases.
A drug-resistant infection involving CRE, VRE, resistant Klebsiella, or another serious bacterial infection may require prolonged hospitalization, infectious disease treatment, and extended courses of IV antibiotics.
Patients in this tier may also develop sepsis, recurrent infection, temporary organ dysfunction, or other complications that substantially increase the length and cost of treatment.
When an Olympus endoscope is suspected of transmitting the infection, attorneys may review the specific scope used, its repair and reprocessing history, the timing of symptoms, laboratory results, and other evidence showing whether the device was contaminated.
Claims may be stronger when medical and device records support a connection between the procedure and the infection and do not identify a more likely alternative source.
A contaminated device claim involving a lengthy hospital stay, repeated treatment, lost income, and significant physical suffering may support substantial damages even when the patient ultimately recovers.
The potential value of a Tier 2 claim depends on the severity of the infection, the treatment required, the duration of recovery, and the strength of the evidence supporting causation.
Tier 3 Olympus scope claims generally involve patients who developed a serious infection requiring hospitalization and substantial treatment but ultimately recovered without permanent organ damage or long-term disability.
These cases may involve several days of inpatient care, antibiotic treatment, diagnostic testing, and follow-up with infectious disease or gastrointestinal specialists.
Some patients may also experience recurrent symptoms or complications requiring future procedures and treatment, even if they eventually return to their prior level of health.
A claim may be stronger when medical records show that symptoms developed soon after a procedure involving an Olympus scope device and device or reprocessing records support allegations involving contamination or an unsafe device.
Not every infection diagnosed after an endoscopic procedure was caused by the scope, so attorneys must also consider recent hospitalizations, antibiotic use, prior infections, and other possible sources of exposure.
Damages in Tier 3 cases may include hospitalization costs, medications, lost wages, pain and suffering, and other losses associated with the infection and recovery period.
Although these claims generally involve less permanent harm than Tier 1 or Tier 2 cases, a hospitalization-level infection can still result in significant medical and financial damages.
Olympus has previously faced lawsuits involving patients who developed serious infections after procedures performed with its reusable scopes.
Many of the earlier cases involved duodenoscopes used during ERCP procedures and infections caused by antibiotic-resistant bacteria.
Several of these claims were resolved through confidential settlements, so the amounts paid to individual patients and families were not publicly disclosed.
Other cases proceeded to trial and produced publicly reported verdicts.
Separately, Olympus Medical Systems has also faced major federal penalties related to its endoscopy business, although those government payments were not compensation for injured patients.
The most notable Olympus scope settlements and verdicts include:
Beyond the individual settlements and verdicts, Olympus has also faced significant federal penalties tied to its endoscopy business.
In 2018, Olympus Medical Systems agreed to pay $85 million after pleading guilty to failing to report adverse infection events involving its duodenoscopes to the FDA.
The company also agreed to pay $646 million to resolve separate allegations involving illegal kickbacks, bribery, and improper marketing practices.
These federal resolutions were not payments to individual patients, but they are part of the broader legal history surrounding Olympus and its medical devices.
You may qualify to file an Olympus scope infection lawsuit if you underwent a colonoscopy, endoscopy, ERCP, bronchoscopy, or another qualifying scope procedure in 2015 or later and subsequently developed a serious infection requiring hospitalization.
These claims can arise after otherwise routine procedures performed at hospitals, outpatient facilities, or surgical centers using Olympus reusable scopes.
TorHoerman Law is reviewing cases involving sepsis, drug-resistant bacterial infections, tuberculosis, and other severe complications that developed after qualifying endoscopy procedures.
A patient may also have grounds for further investigation if a hospital or medical facility issued an exposure notice warning that a scope used during the procedure may have been contaminated.
Reusable endoscopes must be carefully cleaned and disinfected between patients, often with the assistance of automated endoscope reprocessors.
Reprocessing failures can occur when biological material remains inside internal channels, disinfectant does not reach all surfaces, equipment malfunctions, or residual moisture remains inside the device.
CDC materials have linked endoscope-related outbreaks to inadequate cleaning, improper disinfection, equipment failures, and device design concerns.
Olympus-related claims may allege that narrow internal channels, microscopic crevices, complex device components, or inadequate cleaning instructions made safe reuse more difficult and allowed bacteria to remain on or inside the scope.
You may potentially qualify for an Olympus scope lawsuit if:
An Olympus scope claim may proceed under medical product liability law when the evidence supports allegations involving defective design, manufacturing problems, inadequate warnings, inadequate reprocessing instructions, or another device-related failure.
The viability of a claim depends on the specific medical procedures performed, the scope used, the timing and type of infection, the treatment required, and the available evidence connecting the infection to the device.
The deadline for filing an Olympus scope lawsuit depends on state law.
In many states, personal injury and product liability filing deadlines fall within roughly one to three years, although some jurisdictions provide shorter or longer periods.
The limitations period may begin on the date of injury, the date the infection was discovered, or another date established under applicable state law.
Because these deadlines vary, patients who suspect a contaminated Olympus scope contributed to a serious infection should have the timing of their potential claim reviewed promptly.
Evidence is critical in an Olympus scope infection lawsuit because a serious infection after a procedure does not, by itself, establish that the scope caused the illness.
Attorneys use medical records and device documentation to connect the timing of the procedure, the infection diagnosis, and the treatment that followed.
Records from medical professionals can provide the medical proof needed to establish the type and severity of the infection, including whether the patient required hospitalization, antibiotics, ICU care, or additional medical care.
Procedure and device records may also identify the scope manufacturer, model, serial number, and the specific equipment used during surgical procedures or endoscopic procedures.
Regulatory records, recall information, and an adverse event report may provide additional context, but they do not replace patient-specific evidence showing that a contaminated or defective scope contributed to the injury.
Relevant evidence in an Olympus scope infection lawsuit may include:
Damages are the financial and non-financial losses a patient may seek to recover when a serious infection is shown to have resulted from a defective or contaminated medical device.
In an Olympus endoscope lawsuit, lawyers assess damages by reviewing the severity of the infection, the treatment required, the length of hospitalization, and whether the patient suffered permanent complications or needed ongoing care.
They also calculate documented economic losses, including medical bills, lost income, future treatment costs, and reduced earning capacity.
Non-economic damages may account for pain, suffering, disability, emotional distress, and the effect the illness has had on the patient’s daily life and independence.
Claims involving contaminated Olympus endoscopes are evaluated individually, and the amount of compensation available depends on the medical evidence, financial losses, long-term prognosis, and strength of the liability and causation evidence.
Potential damages in an Olympus scope infection lawsuit may include:
TorHoerman Law is reviewing claims from patients who developed serious infections after procedures involving Olympus scopes.
These cases may involve sepsis, drug-resistant bacterial infections, prolonged hospitalization, ICU care, organ damage, recurrent illness, or wrongful death.
Our attorneys can review medical records, procedure reports, device information, infection timelines, reprocessing records, and other evidence to determine whether a contaminated or defective Olympus scope may have contributed to the injury.
We can also evaluate the medical expenses, lost income, long-term health effects, and other damages that may affect the value of a claim.
Because Olympus scope cases depend heavily on patient-specific medical and device evidence, each claim must be evaluated individually.
If you or a loved one developed a serious infection after an Olympus scope procedure, contact TorHoerman Law for a free consultation.
Olympus scope infection claims are handled on a contingency fee basis, meaning there are no upfront attorney fees and the firm is paid only if compensation is recovered.
You can also use the chat feature on this page to begin a free case review and find out whether you may qualify to file an Olympus scope infection lawsuit.
There is currently no reliable average settlement amount for an Olympus scope lawsuit.
Several earlier Olympus infection claims were resolved through confidential settlements, which means the amounts paid to individual patients and families were not publicly disclosed.
The current litigation has also not produced a global settlement, compensation matrix, or enough public resolutions to calculate a meaningful average.
Settlement value may depend on the severity of the infection, hospitalization and treatment required, permanent complications, lost income, pain and suffering, and the strength of the evidence connecting the Olympus scope to the injury.
Wrongful death Olympus scope claims may involve greater damages than non-fatal infection cases because they can include losses associated with the patient’s death in addition to medical expenses incurred before death.
Depending on state law, recoverable damages may include funeral and burial costs, lost financial support, loss of companionship or consortium, and other losses suffered by surviving family members.
The value of a wrongful death claim still depends on the strength of the evidence connecting the Olympus scope to the infection, the circumstances surrounding the death, the patient’s age and earning history, and the damages available under applicable state law.
A fatal outcome does not guarantee a particular settlement amount, but wrongful death claims are generally evaluated as among the most serious Olympus scope cases.
A contaminated endoscope may expose patients to bacteria that can cause serious or life-threatening infections.
Olympus scope litigation and FDA reports have involved infections caused by drug-resistant organisms and other bacteria following endoscopic procedures.
Severe infections can require hospitalization, IV antibiotics, intensive care, or additional procedures and may progress rapidly if not treated.
Reported infections and complications may include:
The FDA has also documented serious adverse events involving Olympus endoscopy equipment, including cases involving hospitalization and death.
Patients who develop fever, chills, severe abdominal symptoms, worsening pain, confusion, difficulty breathing, or other signs of serious infection after an endoscopic procedure should contact a healthcare provider and seek medical care immediately if symptoms are severe or rapidly worsening.
Olympus manufactures reusable scopes used during several diagnostic and therapeutic procedures, including colonoscopy, upper endoscopy, bronchoscopy, and endoscopic retrograde cholangiopancreatography (ERCP).
Many historical infection lawsuits have involved reusable duodenoscopes used during ERCP, but contamination and reprocessing concerns have also involved other types of endoscopes.
The FDA issued recalls and other safety actions involving certain reusable scopes, accessories, and automated endoscope reprocessors manufactured by Olympus.
Whether a patient has a potential claim depends on the exact scope used, the procedure performed, the infection that followed, and the evidence connecting the device to the illness.
Patients who develop unusual or worsening symptoms after an endoscopic procedure should contact the medical provider who performed the procedure or another qualified healthcare professional.
Fever, chills, severe abdominal pain, persistent vomiting, diarrhea, confusion, difficulty breathing, or worsening pain may indicate an infection or another complication that requires evaluation.
If symptoms are severe, sudden, or rapidly progressing, seek medical care immediately rather than waiting for a routine follow-up appointment.
Tell the healthcare provider when the procedure occurred, what type of endoscopy was performed, and when the symptoms began.
Patients should also keep copies of hospital records, laboratory results, exposure notices, and other documentation if a contaminated scope is later suspected.
An Olympus scope infection lawsuit may involve product liability, medical malpractice, or both, depending on what caused the infection.
A product liability claim against Olympus may allege that the device was defectively designed or manufactured or that warnings and reprocessing instructions were inadequate.
A medical malpractice claim may involve allegations that a hospital, surgical center, or other healthcare facility failed to properly clean, disinfect, dry, store, inspect, or maintain the scope before reuse.
In some cases, determining responsibility requires reviewing both the condition of the scope and the way the facility handled reprocessing.
A lawyer can examine procedure records, device identification information, reprocessing logs, infection-control reports, and medical evidence to determine which claims and defendants may apply.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Olympus Scope Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.